Psyence Biomedical Ltd.
PBM
$5.21
-$0.445-7.88%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 0.00% | -165.82% | 0.00% | 105.97% | 0.00% |
| Total Depreciation and Amortization | 0.00% | 33.33% | 0.00% | 800.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.00% | 106.44% | 0.00% | -109.44% | 0.00% |
| Change in Net Operating Assets | 0.00% | -407.63% | 0.00% | 115.17% | 0.00% |
| Cash from Operations | 0.00% | -46.35% | 0.00% | -11.69% | 0.00% |
| Capital Expenditure | 0.00% | 46.88% | 0.00% | -10.34% | 0.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00% | -- | -- | -- | -- |
| Cash from Investing | 0.00% | -53.13% | 0.00% | -10.34% | 0.00% |
| Total Debt Issued | -- | -100.00% | 0.00% | -43.98% | 0.00% |
| Total Debt Repaid | -- | -- | -- | -- | 0.00% |
| Issuance of Common Stock | 0.00% | -98.82% | 0.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | -- | -- | -- | 0.00% |
| Cash from Financing | 0.00% | 136.29% | 0.00% | 82.58% | 0.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 0.00% | 250.39% | 0.00% | 838.50% | 0.00% |